Treatment for many gastrointestinal cancers is becoming increasingly personalized, thanks to advances in genetic research, targeted therapies and a deeper understanding of how individual tumors behave ...

SGMC Health’s Pearlman Cancer Center is now offering Jelmyto, a new chemotherapy treatment for a rare type of kidney cancer called renal pelvis cancer.

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.